Bruce Zuraw is a Rheumatology/Immunology physician affiliated with La Jolla Institute for Immunology. OpenAlex indexes 327 publications with 16,698 citations (h-index 65); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Allergy & Immunology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 West Arbor Drive
Ucsd Medical Center
San Diego, CA 921038201
Telephone
858-657-8322Registry record last updated 10 Aug 2011.
Clinical trials
- Efficacy and Safety Study of BCX7353 as an Oral Treatment for the Prevention of Attacks in HAE
Sponsor: BioCryst Pharmaceuticals
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CSL BehringProgram year20257 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20253 payments
- BioCryst Pharmaceuticals, Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 1986–2023 per NIH RePORTER. The latest:
- Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
Va San Diego Healthcare System
FY2023I01BX004240 - Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
Va San Diego Healthcare System
FY2022I01BX004240 - Mechanisms Underlying the Dominant Negative Phenotype in Hereditary Angioedema
Va San Diego Healthcare System
FY2021I01BX004240
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
World Allergy Organization Journal
2022 - US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema
The Journal of Allergy and Clinical Immunology In Practice
2020 - Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Journal of Allergy and Clinical Immunology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Karen Marder, MD
La Jolla Institute for Immunology
Sydney Leibel, MD
La Jolla Institute for Immunology
Jennifer Dan, MD, PhD
La Jolla Institute for Immunology
Marc Riedl, MD
La Jolla Institute for Immunology
Marc Hochberg, MD
University of Maryland School of Medicine
Michelle Petri, MD
Johns Hopkins University School of Medicine
Dinesh Khanna, MD
University of Michigan
Matthew Liang, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”